We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 20.58%
2 Healthcare 15.8%
3 Financials 11.35%
4 Consumer Discretionary 9.79%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKNG icon
51
Booking.com
BKNG
$156B
$92.6M 0.4%
1,343,875
+203,700
+18% +$14.9M
VZ icon
52
Verizon
VZ
$197B
$92.5M 0.4%
1,645,553
-312,845
-16% -$17.8M
UNP icon
53
Union Pacific
UNP
$173B
$92.5M 0.4%
669,179
-36,301
-5% -$5.38M
CDNS icon
54
Cadence Design Systems
CDNS
$92.6B
$91.7M 0.4%
2,109,260
-148,656
-7% -$6.45M
BRK.B icon
55
Berkshire Hathaway Class B
BRK.B
$1.1T
$91.6M 0.4%
448,555
+13,692
+3% +$2.86M
VRTX icon
56
Vertex Pharmaceuticals
VRTX
$123B
$91.6M 0.4%
552,659
+20,083
+4% +$3.48M
MMM icon
57
3M
MMM
$91.9B
$91.1M 0.4%
571,781
-18,208
-3% -$3.02M
ADSK icon
58
Autodesk
ADSK
$51.8B
$90.1M 0.39%
700,398
+140,221
+25% +$18.9M
PYPL icon
59
PayPal
PYPL
$50.6B
$89.7M 0.39%
1,066,539
+257,529
+32% +$21.4M
TEL icon
60
TE Connectivity
TEL
$60B
$87.7M 0.38%
1,160,130
+196,637
+20% +$15.1M
CL icon
61
Colgate-Palmolive
CL
$75B
$87.7M 0.38%
1,473,811
+647,703
+78% +$40.5M
SBUX icon
62
Starbucks
SBUX
$118B
$87.7M 0.38%
1,361,656
-267,316
-16% -$16.7M
RTN
63
DELISTED
Raytheon Company
RTN
$86.1M 0.38%
561,410
-7,184
-1% -$1.29M
ELV icon
64
Elevance Health
ELV
$81.6B
$85.6M 0.37%
325,934
+97,208
+42% +$26.7M
KMB icon
65
Kimberly-Clark
KMB
$37.4B
$84.6M 0.37%
742,521
+68,968
+10% +$7.65M
CGNX icon
66
Cognex
CGNX
$9.6B
$84.1M 0.37%
2,175,745
+76,127
+4% +$3.3M
BAC icon
67
Bank of America
BAC
$429B
$83M 0.36%
3,369,793
+294,096
+10% +$7.98M
IBM icon
68
IBM
IBM
$213B
$82.9M 0.36%
762,537
-141,054
-16% -$16.9M
UBS icon
69
UBS Group
UBS
$170B
$82.6M 0.36%
6,668,700
-2,290,101
-26% -$31.1M
LLY icon
70
Eli Lilly
LLY
$1.08T
$82.4M 0.36%
712,338
-96,057
-12% -$10.7M
FTI icon
71
TechnipFMC
FTI
$28.7B
$80.5M 0.35%
5,527,238
-552,003
-9% -$10.3M
HUM icon
72
Humana
HUM
$43.8B
$79.3M 0.35%
276,850
+170,494
+160% +$54.1M
MA icon
73
Mastercard
MA
$498B
$78.8M 0.34%
417,573
-54,396
-12% -$10.8M
TER icon
74
Teradyne
TER
$51B
$77.1M 0.34%
2,456,180
-100,043
-4% -$3.39M
MCD icon
75
McDonald's
MCD
$193B
$76.4M 0.33%
430,521
+242,101
+128% +$42.9M

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.